nodes	percent_of_prediction	percent_of_DWPC	metapath
Enzalutamide—AR—polycystic ovary syndrome	0.855	1	CbGaD
Enzalutamide—Bicalutamide—AR—polycystic ovary syndrome	0.00594	0.608	CrCbGaD
Enzalutamide—CYP2C19—urine—polycystic ovary syndrome	0.00492	0.114	CbGeAlD
Enzalutamide—Nilutamide—AR—polycystic ovary syndrome	0.00383	0.392	CrCbGaD
Enzalutamide—CYP2C9—urine—polycystic ovary syndrome	0.00381	0.0884	CbGeAlD
Enzalutamide—CYP3A4—urine—polycystic ovary syndrome	0.00291	0.0674	CbGeAlD
Enzalutamide—CYP2D6—urine—polycystic ovary syndrome	0.00286	0.0663	CbGeAlD
Enzalutamide—AR—adrenal cortex—polycystic ovary syndrome	0.00141	0.0326	CbGeAlD
Enzalutamide—AR—endometrium—polycystic ovary syndrome	0.00126	0.0291	CbGeAlD
Enzalutamide—ALB—adrenal gland—polycystic ovary syndrome	0.00117	0.0271	CbGeAlD
Enzalutamide—AR—uterus—polycystic ovary syndrome	0.00116	0.0268	CbGeAlD
Enzalutamide—AR—pituitary gland—polycystic ovary syndrome	0.00114	0.0263	CbGeAlD
Enzalutamide—AR—adipose tissue—polycystic ovary syndrome	0.00113	0.0262	CbGeAlD
Enzalutamide—CYP2B6—adrenal cortex—polycystic ovary syndrome	0.00102	0.0236	CbGeAlD
Enzalutamide—CYP2C8—endometrium—polycystic ovary syndrome	0.00102	0.0235	CbGeAlD
Enzalutamide—AR—adrenal gland—polycystic ovary syndrome	0.00102	0.0235	CbGeAlD
Enzalutamide—AR—female gonad—polycystic ovary syndrome	0.000947	0.0219	CbGeAlD
Enzalutamide—AR—vagina—polycystic ovary syndrome	0.000941	0.0218	CbGeAlD
Enzalutamide—CYP2C8—pituitary gland—polycystic ovary syndrome	0.000919	0.0213	CbGeAlD
Enzalutamide—AR—endocrine gland—polycystic ovary syndrome	0.000881	0.0204	CbGeAlD
Enzalutamide—CYP2C19—vagina—polycystic ovary syndrome	0.000872	0.0202	CbGeAlD
Enzalutamide—CYP3A5—adipose tissue—polycystic ovary syndrome	0.000826	0.0191	CbGeAlD
Enzalutamide—CYP2C19—endocrine gland—polycystic ovary syndrome	0.000816	0.0189	CbGeAlD
Enzalutamide—CYP2C8—vagina—polycystic ovary syndrome	0.000761	0.0176	CbGeAlD
Enzalutamide—CYP2B6—adrenal gland—polycystic ovary syndrome	0.000737	0.0171	CbGeAlD
Enzalutamide—CYP2C8—endocrine gland—polycystic ovary syndrome	0.000712	0.0165	CbGeAlD
Enzalutamide—CYP3A5—female gonad—polycystic ovary syndrome	0.000691	0.016	CbGeAlD
Enzalutamide—CYP3A5—vagina—polycystic ovary syndrome	0.000687	0.0159	CbGeAlD
Enzalutamide—CYP2B6—vagina—polycystic ovary syndrome	0.000683	0.0158	CbGeAlD
Enzalutamide—ABCB1—embryo—polycystic ovary syndrome	0.000666	0.0154	CbGeAlD
Enzalutamide—CYP3A5—endocrine gland—polycystic ovary syndrome	0.000643	0.0149	CbGeAlD
Enzalutamide—CYP2B6—endocrine gland—polycystic ovary syndrome	0.000639	0.0148	CbGeAlD
Enzalutamide—CYP2C9—endocrine gland—polycystic ovary syndrome	0.000633	0.0147	CbGeAlD
Enzalutamide—ABCB1—adrenal cortex—polycystic ovary syndrome	0.000545	0.0126	CbGeAlD
Enzalutamide—CYP2D6—female gonad—polycystic ovary syndrome	0.00051	0.0118	CbGeAlD
Enzalutamide—ABCB1—endometrium—polycystic ovary syndrome	0.000487	0.0113	CbGeAlD
Enzalutamide—CYP3A4—endocrine gland—polycystic ovary syndrome	0.000482	0.0112	CbGeAlD
Enzalutamide—CYP2D6—endocrine gland—polycystic ovary syndrome	0.000475	0.011	CbGeAlD
Enzalutamide—ABCB1—uterus—polycystic ovary syndrome	0.000449	0.0104	CbGeAlD
Enzalutamide—ABCB1—pituitary gland—polycystic ovary syndrome	0.000441	0.0102	CbGeAlD
Enzalutamide—ABCB1—adipose tissue—polycystic ovary syndrome	0.000439	0.0102	CbGeAlD
Enzalutamide—ABCB1—adrenal gland—polycystic ovary syndrome	0.000394	0.00912	CbGeAlD
Enzalutamide—ABCB1—female gonad—polycystic ovary syndrome	0.000367	0.00851	CbGeAlD
Enzalutamide—ABCB1—vagina—polycystic ovary syndrome	0.000365	0.00845	CbGeAlD
Enzalutamide—ABCB1—endocrine gland—polycystic ovary syndrome	0.000341	0.00791	CbGeAlD
Enzalutamide—Injury—Metformin—polycystic ovary syndrome	0.000229	0.0732	CcSEcCtD
Enzalutamide—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.000188	0.0601	CcSEcCtD
Enzalutamide—Neutropenia—Metformin—polycystic ovary syndrome	0.00017	0.0543	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.000169	0.054	CcSEcCtD
Enzalutamide—Infestation NOS—Metformin—polycystic ovary syndrome	0.000162	0.0518	CcSEcCtD
Enzalutamide—Infestation—Metformin—polycystic ovary syndrome	0.000162	0.0518	CcSEcCtD
Enzalutamide—Rhinitis—Metformin—polycystic ovary syndrome	0.000146	0.0466	CcSEcCtD
Enzalutamide—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.000145	0.0463	CcSEcCtD
Enzalutamide—Oedema peripheral—Metformin—polycystic ovary syndrome	0.000144	0.0458	CcSEcCtD
Enzalutamide—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.000143	0.0457	CcSEcCtD
Enzalutamide—Angiopathy—Metformin—polycystic ovary syndrome	0.000132	0.0422	CcSEcCtD
Enzalutamide—Hypertension—Metformin—polycystic ovary syndrome	0.00011	0.035	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.000107	0.0342	CcSEcCtD
Enzalutamide—Infection—Metformin—polycystic ovary syndrome	0.000103	0.0328	CcSEcCtD
Enzalutamide—Nervous system disorder—Metformin—polycystic ovary syndrome	0.000102	0.0324	CcSEcCtD
Enzalutamide—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.000101	0.0324	CcSEcCtD
Enzalutamide—Skin disorder—Metformin—polycystic ovary syndrome	0.000101	0.0321	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	9.44e-05	0.0301	CcSEcCtD
Enzalutamide—Paraesthesia—Metformin—polycystic ovary syndrome	9.3e-05	0.0297	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	8.94e-05	0.0285	CcSEcCtD
Enzalutamide—Fatigue—Metformin—polycystic ovary syndrome	8.93e-05	0.0285	CcSEcCtD
Enzalutamide—Asthenia—Metformin—polycystic ovary syndrome	7.43e-05	0.0237	CcSEcCtD
Enzalutamide—Pruritus—Metformin—polycystic ovary syndrome	7.33e-05	0.0234	CcSEcCtD
Enzalutamide—Diarrhoea—Metformin—polycystic ovary syndrome	7.09e-05	0.0226	CcSEcCtD
Enzalutamide—Dizziness—Metformin—polycystic ovary syndrome	6.85e-05	0.0219	CcSEcCtD
Enzalutamide—Headache—Metformin—polycystic ovary syndrome	6.49e-05	0.0207	CcSEcCtD
Enzalutamide—CYP2C19—Metabolism—PNPLA2—polycystic ovary syndrome	3.21e-05	0.000359	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	3.19e-05	0.000358	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—HSD3B1—polycystic ovary syndrome	3.19e-05	0.000357	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	3.18e-05	0.000356	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—GNAS—polycystic ovary syndrome	3.13e-05	0.000351	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PNPLA2—polycystic ovary syndrome	3.13e-05	0.000351	CbGpPWpGaD
Enzalutamide—ABCB1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	3.09e-05	0.000347	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—NR3C1—polycystic ovary syndrome	3.09e-05	0.000346	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—SRD5A1—polycystic ovary syndrome	3.04e-05	0.00034	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—LHB—polycystic ovary syndrome	2.97e-05	0.000333	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—SRD5A1—polycystic ovary syndrome	2.97e-05	0.000332	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	2.95e-05	0.00033	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PNPLA2—polycystic ovary syndrome	2.92e-05	0.000327	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	2.91e-05	0.000326	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	2.91e-05	0.000326	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—LHB—polycystic ovary syndrome	2.91e-05	0.000326	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—HSD3B2—polycystic ovary syndrome	2.91e-05	0.000326	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—STAR—polycystic ovary syndrome	2.9e-05	0.000325	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—HMMR—polycystic ovary syndrome	2.89e-05	0.000324	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—HMMR—polycystic ovary syndrome	2.88e-05	0.000323	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	2.87e-05	0.000321	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—HSD3B2—polycystic ovary syndrome	2.84e-05	0.000318	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—STAR—polycystic ovary syndrome	2.83e-05	0.000317	CbGpPWpGaD
Enzalutamide—ABCB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	2.83e-05	0.000317	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—AKR1C1—polycystic ovary syndrome	2.82e-05	0.000316	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	2.79e-05	0.000313	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	2.77e-05	0.00031	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—HSD3B1—polycystic ovary syndrome	2.76e-05	0.000309	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—AKR1C1—polycystic ovary syndrome	2.75e-05	0.000308	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—HSD3B1—polycystic ovary syndrome	2.75e-05	0.000308	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	2.73e-05	0.000306	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	2.71e-05	0.000304	CbGpPWpGaD
Enzalutamide—ALB—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	2.71e-05	0.000304	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	2.7e-05	0.000303	CbGpPWpGaD
Enzalutamide—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	2.7e-05	0.000302	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	2.67e-05	0.000299	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	2.64e-05	0.000296	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	2.61e-05	0.000293	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—SULT2A1—polycystic ovary syndrome	2.59e-05	0.00029	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	2.59e-05	0.00029	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—HMMR—polycystic ovary syndrome	2.58e-05	0.00029	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	2.57e-05	0.000288	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—VEGFA—polycystic ovary syndrome	2.57e-05	0.000288	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—SULT2A1—polycystic ovary syndrome	2.53e-05	0.000284	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	2.53e-05	0.000283	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	2.52e-05	0.000283	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—LHB—polycystic ovary syndrome	2.52e-05	0.000282	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—RRM2—polycystic ovary syndrome	2.51e-05	0.000281	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—LHB—polycystic ovary syndrome	2.5e-05	0.000281	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—HSD3B1—polycystic ovary syndrome	2.46e-05	0.000276	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—HSD3B2—polycystic ovary syndrome	2.46e-05	0.000276	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—RRM2—polycystic ovary syndrome	2.45e-05	0.000275	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—HSD3B2—polycystic ovary syndrome	2.45e-05	0.000274	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	2.44e-05	0.000273	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—YAP1—polycystic ovary syndrome	2.42e-05	0.000271	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	2.41e-05	0.00027	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—PPARG—polycystic ovary syndrome	2.39e-05	0.000268	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—AKR1C1—polycystic ovary syndrome	2.38e-05	0.000267	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	2.38e-05	0.000266	CbGpPWpGaD
Enzalutamide—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	2.37e-05	0.000266	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—AKR1C1—polycystic ovary syndrome	2.37e-05	0.000266	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—YAP1—polycystic ovary syndrome	2.36e-05	0.000265	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	2.36e-05	0.000264	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—NAMPT—polycystic ovary syndrome	2.32e-05	0.00026	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	2.31e-05	0.000259	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	2.3e-05	0.000258	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	2.3e-05	0.000258	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—CYP11A1—polycystic ovary syndrome	2.3e-05	0.000257	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—NAMPT—polycystic ovary syndrome	2.27e-05	0.000255	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	2.27e-05	0.000254	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—LHB—polycystic ovary syndrome	2.25e-05	0.000252	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	2.25e-05	0.000252	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—CYP11A1—polycystic ovary syndrome	2.24e-05	0.000251	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	2.22e-05	0.000249	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—HSD3B2—polycystic ovary syndrome	2.2e-05	0.000246	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—LHB—polycystic ovary syndrome	2.19e-05	0.000246	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—SULT2A1—polycystic ovary syndrome	2.19e-05	0.000246	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—SULT2A1—polycystic ovary syndrome	2.18e-05	0.000244	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—AKR1C3—polycystic ovary syndrome	2.17e-05	0.000243	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—SERPINE1—polycystic ovary syndrome	2.16e-05	0.000242	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	2.14e-05	0.00024	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—CYP17A1—polycystic ovary syndrome	2.13e-05	0.000239	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—AKR1C1—polycystic ovary syndrome	2.13e-05	0.000238	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—RRM2—polycystic ovary syndrome	2.12e-05	0.000238	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—AKR1C3—polycystic ovary syndrome	2.12e-05	0.000237	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—RRM2—polycystic ovary syndrome	2.11e-05	0.000237	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	2.11e-05	0.000236	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—CYP17A1—polycystic ovary syndrome	2.09e-05	0.000234	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	2.08e-05	0.000233	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	2.07e-05	0.000232	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	2.05e-05	0.00023	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—YAP1—polycystic ovary syndrome	2.05e-05	0.000229	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—YAP1—polycystic ovary syndrome	2.04e-05	0.000228	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—IGF1—polycystic ovary syndrome	2.03e-05	0.000227	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—AKT2—polycystic ovary syndrome	2.03e-05	0.000227	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	2.02e-05	0.000226	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	2e-05	0.000224	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—NAMPT—polycystic ovary syndrome	1.97e-05	0.00022	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—SULT2A1—polycystic ovary syndrome	1.96e-05	0.000219	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	1.96e-05	0.000219	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—NAMPT—polycystic ovary syndrome	1.96e-05	0.000219	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.96e-05	0.000219	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.94e-05	0.000218	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—CYP11A1—polycystic ovary syndrome	1.94e-05	0.000218	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	1.94e-05	0.000217	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—CYP11A1—polycystic ovary syndrome	1.93e-05	0.000217	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.93e-05	0.000216	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	1.93e-05	0.000216	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—SERPINE1—polycystic ovary syndrome	1.92e-05	0.000216	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.92e-05	0.000215	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	1.91e-05	0.000214	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—RRM2—polycystic ovary syndrome	1.9e-05	0.000212	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	1.85e-05	0.000207	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—TH—polycystic ovary syndrome	1.85e-05	0.000207	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—AKR1C3—polycystic ovary syndrome	1.83e-05	0.000206	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—YAP1—polycystic ovary syndrome	1.83e-05	0.000205	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	1.83e-05	0.000205	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—AKR1C3—polycystic ovary syndrome	1.82e-05	0.000204	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—CYP17A1—polycystic ovary syndrome	1.81e-05	0.000202	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—TH—polycystic ovary syndrome	1.8e-05	0.000202	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	1.8e-05	0.000202	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—CYP17A1—polycystic ovary syndrome	1.8e-05	0.000201	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—SLC2A4—polycystic ovary syndrome	1.8e-05	0.000201	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	1.79e-05	0.0002	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	1.78e-05	0.0002	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—NAMPT—polycystic ovary syndrome	1.76e-05	0.000197	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—SLC2A4—polycystic ovary syndrome	1.76e-05	0.000197	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.75e-05	0.000196	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	1.74e-05	0.000195	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	1.74e-05	0.000195	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CYP11A1—polycystic ovary syndrome	1.73e-05	0.000194	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	1.73e-05	0.000194	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.72e-05	0.000193	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	1.71e-05	0.000192	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	1.69e-05	0.00019	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—CYP19A1—polycystic ovary syndrome	1.69e-05	0.000189	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	1.68e-05	0.000188	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	1.67e-05	0.000187	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—CYP19A1—polycystic ovary syndrome	1.65e-05	0.000185	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—AKR1C3—polycystic ovary syndrome	1.64e-05	0.000184	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	1.62e-05	0.000181	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CYP17A1—polycystic ovary syndrome	1.61e-05	0.000181	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	1.6e-05	0.000179	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	1.6e-05	0.000179	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	1.6e-05	0.000179	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.59e-05	0.000178	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	1.58e-05	0.000177	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	1.57e-05	0.000176	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.57e-05	0.000176	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—TH—polycystic ovary syndrome	1.56e-05	0.000175	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—TH—polycystic ovary syndrome	1.55e-05	0.000174	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	1.55e-05	0.000174	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—SLC2A4—polycystic ovary syndrome	1.52e-05	0.00017	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—SLC2A4—polycystic ovary syndrome	1.51e-05	0.000169	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—GNAS—polycystic ovary syndrome	1.51e-05	0.000169	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	1.51e-05	0.000169	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	1.49e-05	0.000167	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	1.48e-05	0.000166	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	1.48e-05	0.000166	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—GNAS—polycystic ovary syndrome	1.47e-05	0.000165	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	1.47e-05	0.000165	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—NCOR1—polycystic ovary syndrome	1.44e-05	0.000161	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—CYP19A1—polycystic ovary syndrome	1.43e-05	0.00016	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—CYP19A1—polycystic ovary syndrome	1.42e-05	0.000159	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—NCOR1—polycystic ovary syndrome	1.4e-05	0.000157	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—TH—polycystic ovary syndrome	1.4e-05	0.000156	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—TH—polycystic ovary syndrome	1.36e-05	0.000153	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—CYP1A1—polycystic ovary syndrome	1.36e-05	0.000153	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—SLC2A4—polycystic ovary syndrome	1.36e-05	0.000152	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	1.35e-05	0.000151	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—CYP1A1—polycystic ovary syndrome	1.33e-05	0.000149	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	1.32e-05	0.000148	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—VEGFA—polycystic ovary syndrome	1.32e-05	0.000148	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	1.32e-05	0.000148	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—TH—polycystic ovary syndrome	1.28e-05	0.000144	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	1.28e-05	0.000143	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CYP19A1—polycystic ovary syndrome	1.28e-05	0.000143	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—GNAS—polycystic ovary syndrome	1.28e-05	0.000143	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—TH—polycystic ovary syndrome	1.27e-05	0.000143	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—MTHFR—polycystic ovary syndrome	1.27e-05	0.000142	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—GNAS—polycystic ovary syndrome	1.27e-05	0.000142	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	1.25e-05	0.00014	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	1.25e-05	0.00014	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—MTHFR—polycystic ovary syndrome	1.24e-05	0.000139	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	1.24e-05	0.000139	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—NCOR1—polycystic ovary syndrome	1.22e-05	0.000136	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—NCOR1—polycystic ovary syndrome	1.21e-05	0.000135	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	1.18e-05	0.000132	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	1.17e-05	0.000132	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	1.16e-05	0.00013	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—CYP1A1—polycystic ovary syndrome	1.15e-05	0.000129	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—CYP1A1—polycystic ovary syndrome	1.15e-05	0.000128	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	1.14e-05	0.000128	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—GNAS—polycystic ovary syndrome	1.14e-05	0.000128	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	1.11e-05	0.000125	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	1.1e-05	0.000123	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—NCOR1—polycystic ovary syndrome	1.08e-05	0.000122	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—MTHFR—polycystic ovary syndrome	1.07e-05	0.00012	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—MTHFR—polycystic ovary syndrome	1.07e-05	0.00012	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	1.06e-05	0.000119	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	1.06e-05	0.000118	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	1.05e-05	0.000117	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	1.04e-05	0.000117	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	1.04e-05	0.000116	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PPARG—polycystic ovary syndrome	1.03e-05	0.000115	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CYP1A1—polycystic ovary syndrome	1.03e-05	0.000115	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—POMC—polycystic ovary syndrome	1.01e-05	0.000114	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—INS—polycystic ovary syndrome	1.01e-05	0.000113	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PPARG—polycystic ovary syndrome	1.01e-05	0.000113	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	1e-05	0.000112	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	9.98e-06	0.000112	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—POMC—polycystic ovary syndrome	9.92e-06	0.000111	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	9.89e-06	0.000111	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—INS—polycystic ovary syndrome	9.86e-06	0.000111	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	9.85e-06	0.00011	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	9.7e-06	0.000109	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—MTHFR—polycystic ovary syndrome	9.59e-06	0.000107	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	9.46e-06	0.000106	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	9.38e-06	0.000105	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	9.36e-06	0.000105	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	8.82e-06	9.88e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	8.74e-06	9.8e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PPARG—polycystic ovary syndrome	8.71e-06	9.76e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PPARG—polycystic ovary syndrome	8.66e-06	9.71e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—POMC—polycystic ovary syndrome	8.59e-06	9.63e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—INS—polycystic ovary syndrome	8.54e-06	9.57e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—POMC—polycystic ovary syndrome	8.54e-06	9.57e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—INS—polycystic ovary syndrome	8.5e-06	9.52e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—TH—polycystic ovary syndrome	8.39e-06	9.4e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	8.16e-06	9.15e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PPARG—polycystic ovary syndrome	7.78e-06	8.71e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	7.67e-06	8.6e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—POMC—polycystic ovary syndrome	7.67e-06	8.59e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—INS—polycystic ovary syndrome	7.63e-06	8.55e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	7.59e-06	8.5e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—POMC—polycystic ovary syndrome	7.48e-06	8.39e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—INS—polycystic ovary syndrome	7.44e-06	8.34e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	7.15e-06	8.01e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	7.09e-06	7.94e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	7.05e-06	7.9e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—INS—polycystic ovary syndrome	7.01e-06	7.86e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	6.99e-06	7.84e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—INS—polycystic ovary syndrome	6.95e-06	7.79e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	6.85e-06	7.67e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	6.52e-06	7.31e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	6.18e-06	6.93e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	5.77e-06	6.46e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	4.68e-06	5.24e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	4.61e-06	5.17e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—INS—polycystic ovary syndrome	4.59e-06	5.14e-05	CbGpPWpGaD
